Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability Study of Magne-B6 New Formulation vs Solution in Healthy Volunteers
NCT06386211Phase 1Completed
- Sponsor
- Sanofi
- Start
- Jul 2024
- Primary completion
- Aug 2024
- Modality
- Implantable Devices, Transdermal Patches, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vitamin b6 + magnesium in magnesium deficiency (2 arms), sponsored by Sanofi. Primary endpoints: Maximal Observed Concentration of Magnesium in Plasma, Area Under the Concentration-time Curve from Time Zero Until time 12 hour of Magnesium in Plasma and 7 more. Started Jul 2024; status: completed.
02
Drugs
vitamin b6 + magnesium
03
Conditions
magnesium deficiency
Beyond the preview
Go deeper on NCT06386211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06386211.